Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $112.24 billion. The enterprise value is $131.42 billion.
| Market Cap | 112.24B |
| Enterprise Value | 131.42B |
Important Dates
The next estimated earnings date is Tuesday, November 17, 2026, before market open.
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | Sep 25, 2026 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 87.14% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 21.62 and the forward PE ratio is 14.60. Medtronic's PEG ratio is 3.65.
| PE Ratio | 21.62 |
| Forward PE | 14.60 |
| PS Ratio | 2.99 |
| Forward PS | 2.87 |
| PB Ratio | 2.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.30 |
| P/OCF Ratio | 13.97 |
| PEG Ratio | 3.65 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.63, with an EV/FCF ratio of 21.43.
| EV / Earnings | 25.12 |
| EV / Sales | 3.50 |
| EV / EBITDA | 12.63 |
| EV / EBIT | 17.42 |
| EV / FCF | 21.43 |
Financial Position
The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.55.
| Current Ratio | 2.07 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 2.63 |
| Debt / FCF | 4.59 |
| Interest Coverage | 10.41 |
Financial Efficiency
Return on equity (ROE) is 10.65% and return on invested capital (ROIC) is 8.59%.
| Return on Equity (ROE) | 10.65% |
| Return on Assets (ROA) | 5.12% |
| Return on Invested Capital (ROIC) | 8.59% |
| Return on Capital Employed (ROCE) | 9.26% |
| Weighted Average Cost of Capital (WACC) | 6.30% |
| Revenue Per Employee | $395,179 |
| Profits Per Employee | $55,063 |
| Employee Count | 95,000 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.15 |
Taxes
In the past 12 months, Medtronic has paid $1.33 billion in taxes.
| Income Tax | 1.33B |
| Effective Tax Rate | 20.19% |
Stock Price Statistics
The stock price has decreased by -10.76% in the last 52 weeks. The beta is 0.57, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -10.76% |
| 50-Day Moving Average | 90.05 |
| 200-Day Moving Average | 88.42 |
| Relative Strength Index (RSI) | 45.53 |
| Average Volume (20 Days) | 24,987,428 |
Short Selling Information
The latest short interest is 17.23 million, so 1.35% of the outstanding shares have been sold short.
| Short Interest | 17.23M |
| Short Previous Month | 14.35M |
| Short % of Shares Out | 1.35% |
| Short % of Float | 1.35% |
| Short Ratio (days to cover) | 2.17 |
Income Statement
In the last 12 months, Medtronic had revenue of $37.54 billion and earned $5.23 billion in profits. Earnings per share was $4.06.
| Revenue | 37.54B |
| Gross Profit | 24.50B |
| Operating Income | 7.55B |
| Pretax Income | 6.60B |
| Net Income | 5.23B |
| EBITDA | 10.41B |
| EBIT | 7.55B |
| Earnings Per Share (EPS) | $4.06 |
Balance Sheet
The company has $8.82 billion in cash and $28.15 billion in debt, with a net cash position of -$19.17 billion or -$14.99 per share.
| Cash & Cash Equivalents | 8.82B |
| Total Debt | 28.15B |
| Net Cash | -19.17B |
| Net Cash Per Share | -$14.99 |
| Equity (Book Value) | 50.85B |
| Book Value Per Share | 39.24 |
| Working Capital | 12.59B |
Cash Flow
In the last 12 months, operating cash flow was $8.04 billion and capital expenditures -$1.90 billion, giving a free cash flow of $6.13 billion.
| Operating Cash Flow | 8.04B |
| Capital Expenditures | -1.90B |
| Depreciation & Amortization | 2.86B |
| Net Borrowing | 151.00M |
| Free Cash Flow | 6.13B |
| FCF Per Share | $4.79 |
Margins
Gross margin is 65.27%, with operating and profit margins of 20.10% and 13.93%.
| Gross Margin | 65.27% |
| Operating Margin | 20.10% |
| Pretax Margin | 17.59% |
| Profit Margin | 13.93% |
| EBITDA Margin | 27.72% |
| EBIT Margin | 20.10% |
| FCF Margin | 16.33% |
Dividends & Yields
This stock pays an annual dividend of $2.88, which amounts to a dividend yield of 3.28%.
| Dividend Per Share | $2.88 |
| Dividend Yield | 3.28% |
| Dividend Growth (YoY) | 1.42% |
| Years of Dividend Growth | 50 |
| Payout Ratio | 70.94% |
| FCF Payout Ratio | 60.08% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 3.28% |
| Earnings Yield | 4.66% |
| FCF Yield | 5.46% |
Analyst Forecast
The average price target for Medtronic is $104.44, which is 19.02% higher than the current price. The consensus rating is "Buy".
| Price Target | $104.44 |
| Price Target Difference | 19.02% |
| Analyst Consensus | Buy |
| Analyst Count | 29 |
| Revenue Growth Forecast (3Y) | 5.22% |
| EPS Growth Forecast (3Y) | 7.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.98 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.98 |
| Piotroski F-Score | 7 |